Source: http://www.google.es/patents/US9731136
Timestamp: 2018-01-22 16:43:21
Document Index: 364214981

Matched Legal Cases: ['Application No. 13826807', 'Application No. 13826807', 'Application No. 201380072479', 'Application No. 13826807', 'Application No. 201380072479', 'Application No. 13826807']

Patente US9731136 - Methods and apparatus to stimulate the heart - Google Patentes
A method and apparatus for treatment of hypertension and heart failure by increasing secretion of endogenous atrial hormones by pacing of the heart. Pacing is done during the ventricular refractory period resulting in premature atrial contraction that does not result in ventricular contraction. Pacing...http://www.google.es/patents/US9731136?utm_source=gb-gplus-sharePatente US9731136 - Methods and apparatus to stimulate the heart
Número de publicación US9731136 B2
Número de solicitud US 15/163,078
También publicado como US8340763, US9370661, US20100094370, US20130331901, US20160263383, US20170291032
Número de publicación 15163078, 163078, US 9731136 B2, US 9731136B2, US-B2-9731136, US9731136 B2, US9731136B2
Citas de patentes (62), Otras citas (49), Clasificaciones (11), Eventos legales (1)
US 9731136 B2
US20170072203 8 Sep 2016 16 Mar 2017 Backbeat Medical, Inc. Methods and Systems for Treating Cardiac Malfunction
US20170080235 8 Dic 2016 23 Mar 2017 Backbeat Medical, Inc. Methods And Systems For Controlling Blood Pressure By Controlling Atrial Pressure
WO2017044794A1 9 Sep 2016 16 Mar 2017 Backbeat Medical, Inc. Methods and systems for treating cardiac malfunction
2 Advisory Action mailed Apr. 18, 2016 in U.S. Appl. No. 13/960,015.
3 Amendment filed Apr. 7, 2016 in U.S. Appl. No. 13/960,015.
4 Amendment filed Dec. 3, 2015 in U.S. Appl. No. 13/960,015.
5 Amendment filed Jan. 13, 2016 in U.S. Appl. No. 14/427,478.
6 Amendment filed Jan. 19, 2017 in U.S. Appl. No. 13/960,015.
7 Amendment filed Jul. 25, 2016 in U.S. Appl. No. 14/667,931.
8 Amendment filed Jun. 6, 2016 in U.S. Appl. No. 13/960,015.
9 Amendment filed Nov. 30, 2015 in U.S. Appl. No. 13/957,499.
10 Amendment filed Oct. 9, 2015 in U.S. Appl. No. 14/642,952.
11 Amendment filed Sep. 27, 2016 in U.S. Appl. No. 15/143,742.
12 Arbel et al., "Successful Treatment of Drug-Resistant Atrial Tachycardia and Intractable Congestive Heart Failure with Permanent Coupled Atrial Pacing," pp. 336-340, vol. 41 (Am. J. or Cardiology Feb. 1978).
13 Braunwald et al., "Editorial: Paired Electrical Stimulation of the Heart: A Physiologic Riddle and a Clinical Challenge," pp. 677-681, vol. 32, No. 5 (Circulation Nov. 1965).
14 Calderone, Angelino "The Therapeutic Effect of Natriuretic Peptides in Heart Failure; Differential Regulation of Endothelial and Inducible Nitric Oxide Synthases" Heart Failure Reviews, 2003;8;55-70.
15 Decision to Grant dated May 26, 2017 in European Patent Application No. 13826807.3.
16 Final Office Action mailed Jan. 20, 2016 in U.S. Appl. No. 13/960,015.
17 Han, Bo et al., "Cardiovascular Effects of Natriuretic Peptides and Their Interrelation with Endothelin-1" Cardiovascular Drugs and Therapy, 2003;17;41-42.
18 Lister et al., "The Hemodynamic Effect of Slowing the Heart Rate by Paired or Coupled Stimulation of the Atria", pp. 362-368 (Am. Heart J. Mar. 1967).
19 Lopez et al., "Reducing Heart Rate of the Dog by Electrical Stimulation", pp. 414-429, vol. 15 (Circ. Res. 1964).
20 Nishimura, Kazunobu et al., "Atrial pacing stimulates secretion of atrial natriuretic polypeptide without elevation of atrial pressure in awake dogs with experimental complete atrioventricular block." Circ. Res. 1990;66;115-122.
21 Notice of Allowance issued Aug. 17, 2016 in U.S. Appl. No. 14/667,931.
22 Notice of Allowance issued Jan. 18, 2017 in U.S. Appl. No. 15/143,742.
23 Notice of Allowance mailed Apr. 13, 2016 in U.S. Appl. No. 13/957,499.
24 Notice of Allowance mailed Dec. 16, 2014 in U.S. Appl. No. 13/826,215.
26 Notice of Allowance mailed Feb. 22, 2017 in U.S. Appl. No. 13/960,015.
27 Notice of Allowance mailed Jan. 8, 2016 in U.S. Appl. No. 14/642,952.
28 Notice of Intention to Grant issued Jan. 3, 2017 in European Patent Application No. 13826807.3.
29 Office Action dated Mar. 24, 2017 in U.S. Appl. No. 15/372,603.
30 Office Action issued Sep. 5, 2016 in Chinese Patent Application No. 201380072479.3, and English translation thereof.
31 Office Action mailed Jul. 13, 2015 in U.S. Appl. No. 14/642,952.
32 Office Action mailed Jul. 21, 2016 in U.S. Appl. No. 13/960,015.
33 Office Action mailed Jun. 10, 2015 in U.S. Appl. No. 13/960,015.
34 Office Action mailed Jun. 28, 2016 in U.S. Appl. No. 15/143,742.
35 Office Action mailed Jun. 4, 2015 in U.S. Appl. No. 13/957,499.
36 Office Action mailed Mar. 4, 2016 in U.S. Appl. No. 14/667,931.
37 Office Action mailed May 27, 2016 in European Patent Application No. 13826807.3.
38 Office Action mailed Nov. 4, 2015 in U.S. Appl. No. 14/427,478.
39 PCT Invitation to Pay Additional Fees mailed Oct. 17, 2014 in International Application No. PCT/US2014/042777.
40 PCT Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority; Declaration of Non-Establishment of International Search Report; and PCT Written Opinion of International Searching Authority, mailed Apr. 24, 2014 in International Application No. PCT/US2013/076600.
41 PCT Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority; International Search Report; and Written Opinion, mailed Jan. 2, 2015 in International Application No. PCT/US2014/042777.
42 PCT Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority; International Search Report; and Written Opinion, mailed Nov. 28, 2016 in International Application No. PCT/US2016/051023.
43 Response to Office Action filed Jan. 19, 2017 in Chinese Patent Application No. 201380072479.3, and English translation thereof.
44 Response to Office Action filed Sep. 27, 2016 in European Patent Application No. 13826807.3.
45 Schooderwoerd et al., "Atrial Natriuretic Peptides During Experimental Atrial Tachycardia: Role of Developing Tachycardiomyopathy," pp. 927-932, vol. 15, No. 8 (J. of Cardiovascular Electrophysiology Aug. 2004).
46 Siddons et al., Cardiac Pacemakers, pp. 200-217, Pub. No. 680 of American Lecture Series (1968, Charles Thomas Publisher).
47 Willems, Rik M.D. et al., "Different Patterns of Angiotensin II and Atrial Natriuretic Peptide Secretion in a Sheep Model of Atrial Fibrillation." Journal of Cardiovascular Electrophysiology. 2001;12.12;1387-1392.
48 Zupan, Igor et al. "Effects of Systolic Atrial Function on Plasma Renin Activity and Natriuretic Peptide Secretion after-High Rate Atrial and Ventricular Pacing in Dogs." Pace. 2005;28.Supp 1;S270-S274.
49 Zupan, Igor et al. "Effects of Systolic Atrial Function on Plasma Renin Activity and Natriuretic Peptide Secretion after—High Rate Atrial and Ventricular Pacing in Dogs." Pace. 2005;28.Supp 1;S270-S274.
Clasificación internacional A61N1/362, A61N1/365, A61N1/36, A61N1/368
Clasificación cooperativa A61N1/368, A61N1/3627, A61N1/3621, A61N1/36542, A61N1/36564, A61N1/3684, A61N1/36117